Skip to main content
Year archive

Oncopeptides — 2018 filings

All 44 regulatory filings released by Oncopeptides (ONCO) in 2018, sourced directly from the official regulator.

44 Filings
2018 Period
2018 filings (44)
Filing Released Lang
Kommuniké från extra bolagstämma i Oncopeptides AB (publ)
AGM Information
2018-12-05 Swedish
Bulletin from the Extraordinary General Meeting in Oncopeptides AB (PUBL)
Remuneration Information
2018-12-05 English
Interim data from the ongoing HORIZON trial with melflufen presented in an oral presentation at the 60th American Society of Hematology Meeting
Earnings Release FY 2018
2018-12-03 English
Interimsdata från den pågående HORIZON-studien med melflufen presenteras i en muntlig presentation vid det 60:e Amerikanska Hematologimötet (ASH)
Earnings Release FY 2018
2018-12-03 Swedish
Oncopeptides presents first interim data from the ongoing combination trial ANCHOR with melflufen at the 60th American Society of Hematology Meeting
Earnings Release FY 2018
2018-12-01 English
Oncopeptides presenterar de första interimsresultaten från den pågående kombinationsstudien ANCHOR med melflufen vid det amerikanska hematologimötet
Earnings Release FY 2018
2018-12-01 Swedish
Antal aktier och röster i Oncopeptides
Share Issue/Capital Change
2018-11-30 Swedish
Number of shares and votes in Oncopeptides
Share Issue/Capital Change
2018-11-30 English
EXTRAORDINARY GENERAL MEETING IN ONCOPEPTIDES AB (PUBL)
AGM Information
2018-11-05 English
EXTRA BOLAGSSTÄMMA I ONCOPEPTIDES AB (PUBL)
AGM Information
2018-11-05 Swedish
Oncopeptides to present updated data from the two ongoing trials ANCHOR and HORIZON in patients with RRMM at ASH in December 2018
Regulatory Filings
2018-11-01 English
Oncopeptides kommer att presentera uppdaterade data från två pågående studier, ANCHOR och HORIZON, i RRMM patienter vid ASH-mötet i december 2018
Regulatory Filings
2018-11-01 Swedish
Antal aktier och röster i Oncopeptides
Declaration of Voting Results & Voting Rights Announcements
2018-10-31 Swedish
Number of shares and votes in Oncopeptides
Declaration of Voting Results & Voting Rights Announcements
2018-10-31 English
Interim / Quarterly Report 2018
Interim / Quarterly Report Q3 2018
2018-10-26 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report Q3 2018
2018-10-26 English
Antal aktier och röster i Oncopeptides
Declaration of Voting Results & Voting Rights Announcements
2018-08-31 Swedish
Number of shares and votes in Oncopeptides
Share Issue/Capital Change
2018-08-31 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-08-16 English
Anders Martin-Löf has been appointed as the new CFO of Oncopeptides
Board/Management Information
2018-08-09 English
Oncopeptides utser Anders Martin-Löf som ny Chief Financial Officer
Board/Management Information
2018-08-09 Swedish
Number of shares and votes in Oncopeptides
Share Issue/Capital Change
2018-07-31 English
Antal aktier och röster i Oncopeptides
Declaration of Voting Results & Voting Rights Announcements
2018-07-31 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report Q2 2018
2018-07-13 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report Q2 2018
2018-07-13 English
Oncopeptides presenterar idag uppdaterade interimsdata från den pågående HORIZON-studien med Ygalo® på det europeiska hematologimötet (EHA)
Earnings Release FY 2018
2018-06-15 Swedish
Oncopeptides present updated interim data from the ongoing HORIZON trial with Ygalo® at the 23rd Congress of The European Hematology Association (EHA)
Earnings Release FY 2018
2018-06-15 English
Kommuniké från årsstämma i Oncopeptides AB (Publ)
AGM Information
2018-05-17 Swedish
Bulletin from the Annual General Meeting in Oncopeptides AB (Publ)
AGM Information
2018-05-17 English
Interim / Quarterly Report 2018
Interim / Quarterly Report Q1 2018
2018-05-17 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report Q1 2018
2018-05-17 English
Annual Report 2017
Annual Report FY 2017
2018-04-18 Swedish
Annual Report 2017
Annual Report FY 2017
2018-04-18 English
ÅRSSTÄMMA I ONCOPEPTIDES AB (PUBL)
AGM Information
2018-04-17 Swedish
ANNUAL GENERAL MEETING IN ONCOPEPTIDES AB (PUBL)
AGM Information
2018-04-17 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-04-04 English
Antal aktier och röster i Oncopeptides
Declaration of Voting Results & Voting Rights Announcements
2018-03-29 Swedish
Number of shares and votes in Oncopeptides
Declaration of Voting Results & Voting Rights Announcements
2018-03-29 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-03-23 English
Oncopeptides has completed a directed share issue of approximately SEK 314 million
Capital/Financing Update
2018-03-22 English
Oncopeptides har genomfört en riktad nyemission om cirka 314 miljoner kronor
Share Issue/Capital Change
2018-03-22 Swedish
Oncopeptides avser att genomföra en riktad nyemission
Share Issue/Capital Change
2018-03-21 Swedish
Earnings Release 2017
Earnings Release Q4 2017
2018-02-22 Swedish
Interim / Quarterly Report 2017
Interim / Quarterly Report Q4 2017
2018-02-22 English